Technical Analysis for CLVLY - Clinuvel Pharm ADR

Grade Last Price % Change Price Change
grade B 18.25 0.30% 0.0550
CLVLY closed up 0.3 percent on Friday, August 23, 2019, on 25 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Up
See historical CLVLY trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Bearish Engulfing Bearish 0.30%
Narrow Range Bar Range Contraction 0.30%
Wide Bands Range Expansion 0.30%
Oversold Stochastic Weakness 0.30%
Shooting Star Candlestick Bearish 0.00%
Crossed Above 200 DMA Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%

Older signals for CLVLY ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Clinuvel Pharmaceuticals Limited is a biopharmaceutical company. The Company is focused on developing drugs for the treatment of a range of severe skin disorders. Its lead compound, SCENESSE (afamelanotide 16 milligrams), prevents phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company focuses at preventing the symptoms of skin diseases related to the exposure to harmful ultra violet (UV) radiation and at repigmentation of the skin due to a number of depigmentation disorders. SCENESSE has completed Phase II and III trials in the United States and Europe, and has been granted marketing authorization by the European Commission for adults with EPP. It has operations in Europe, the United States and Singapore. SCENESSE acts by increasing the levels of melanin in the skin and shields against UV radiation (UVR) and sunlight. SCENESSE is delivered via a subcutaneous dissolving implant.
Branches Of Biology Biopharmaceutical United States Organ Systems Radiation Burns Skin Diseases Ultraviolet Peptides Severe Skin Disorders Treatment Of A Range Of Severe Skin Disorders
Is CLVLY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 26.75
52 Week Low 8.66
Average Volume 15,400
200-Day Moving Average 17.9871
50-Day Moving Average 22.0534
20-Day Moving Average 19.2086
10-Day Moving Average 17.9675
Average True Range 0.6334
ADX 31.1
+DI 28.8516
-DI 45.0634
Chandelier Exit (Long, 3 ATRs ) 21.1398
Chandelier Exit (Short, 3 ATRs ) 18.7102
Upper Bollinger Band 22.7005
Lower Bollinger Band 15.7167
Percent B (%b) 0.36
BandWidth 36.357673
MACD Line -1.2257
MACD Signal Line -1.2803
MACD Histogram 0.0546
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.6250
Resistance 3 (R3) 18.6667 18.5833 18.5625
Resistance 2 (R2) 18.5833 18.4878 18.5625 18.5417
Resistance 1 (R1) 18.4167 18.4288 18.3750 18.3750 18.5208
Pivot Point 18.3333 18.3333 18.3125 18.3125 18.3333
Support 1 (S1) 18.1667 18.2378 18.1250 18.1250 17.9792
Support 2 (S2) 18.0833 18.1788 18.0625 17.9584
Support 3 (S3) 17.9167 18.0833 17.9375
Support 4 (S4) 17.8750